This hypothesized modulation of GLP-1 concentrations could improve incretin sensitivity of pancreatic β-cells and promote greater insulin secretion after an oral glucose load, thus lowering susceptibility to T2DM in G-allele carriers [24]. The gene discussed is INS; the disease is type 2 diabetes mellitus.